UK – National Institute for Health and Care Excellence (NICE) Issues MedTech Innovation Briefing on ‘Trublood®- Prostate’ for Precision Non-invasive Prostate Cancer Diagnosis Described by Experts as a ‘Game Changer’
MUMBAI, India and LONDON, July 13, 2021 /PRNewswire/ -- Datar Cancer Genetics, a world leading non-invasive cancer analytics and diagnostics company having its Research Head...